In the past half century, deadly disease outbreaks caused by novel viruses of animal origin — Nipah virus in Malaysia, Hendra virus in Australia, Hantavirus in the United States, Ebola virus in Africa, along with HIV (human immunodeficiency virus), several influenza subtypes, and the SARS (sudden acute respiratory syndrome) and MERS (Middle East respiratory syndrome) coronaviruses — have underscored the urgency of understanding factors influencing viral disease emergence and spread.

Emerging Viral Diseases is the summary of a public workshop hosted in March 2014 to examine factors driving the appearance, establishment, and spread of emerging, re-emerging and novel viral diseases; the global health and economic impacts of recently emerging and novel viral diseases in humans; and the scientific and policy approaches to improving domestic and international capacity to detect and respond to global outbreaks of infectious disease. This report is a record of the presentations and discussion of the event.

Contents

• THE NATIONAL ACADEMIES
• PLANNING COMMITTEE FOR THE WORKSHOP ON EMERGING VIRAL DISEASES
• FORUM ON MICROBIAL THREATS
• BOARD ON GLOBAL HEALTH
• Reviewers
• Acknowledgments
• Workshop Overview
  • EMERGING VIRAL DISEASES—THE ONE HEALTH CONNECTION
  • IMPACT OF EMERGING VIRAL DISEASES
  • LESSONS LEARNED FROM THE 2009 H1N1 INFLUENZA A PANDEMIC
  • OVERVIEW OF EMERGING VIRAL DISEASES
  • EMERGENCE OF MERS-COV
  • EMERGENCE OF INFLUENZA A VIRUSES IN ASIA
  • INTERNATIONAL AND DOMESTIC RESPONSES TO EMERGING VIRAL DISEASES
  • References
• Appendixes
  • A Contributed Manuscripts
  • Appendix B Agenda
  • Appendix C Acronyms
  • Appendix D Glossary
  • Appendix E Speaker Biographies

Rapporteurs: Eileen R. Choffnes and Alison Mack.

Financial support for this activity was provided by the U.S. Department of Health and Human Services: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Centers for Disease Control and Prevention, and the Food and Drug Administration; U.S. Department of Defense: Armed Forces Health Surveillance Center, and U.S. Army Medical Research and Materiel Command; U.S. Department of Justice: Federal Bureau of Investigation; U.S. Department of Veterans Affairs; U.S. Department of Homeland Security; U.S. Agency for International Development; Uniformed Services University of the Health Sciences; Alfred P. Sloan Foundation; American Society for Microbiology; Infectious Diseases Society of America; Johnson & Johnson; Merck Company Foundation; and sanofi pasteur. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provided support for this activity.

Suggested citation:

IOM (Institute of Medicine). 2015. Emerging Viral Diseases: The One Health Connection. Washington, DC: The National Academies Press.

NOTICE: The workshop that is the subject of this workshop summary was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine.